Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TEDMED In Brief

This article was originally published in The Gray Sheet

Executive Summary

Last week's TEDMED conference in Washington, D.C., touted as a gathering of visionaries imagining the future of health and medicine, welcomed U.S. Chief Technology Officer Todd Park and a host of other medtech policymakers and entrepreneurs.

You may also be interested in...



"More Innovation, More Affordably" Named A Top Challenge At TEDMED

Delegates at April's TEDMED conference rallied around the notion that moving innovative products through FDA more quickly is essential to advancing health care.

HHS Open Government Plan Offers Vastly More Information On FDA, CMS

The Department of Health and Human Services' open government plan, unveiled April 7, includes an online "FDA Track" site to measure FDA's performance and a "CMS Dashboard" that provides easier access to certain Medicare payment data

QUOTED. 1 December. Rob Field.

UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.

Topics

UsernamePublicRestriction

Register

LL026487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel